Ticker
LSTACompany Name
LISATA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -16.4M | -1533.08% | $ 1.07M |
3/31/2025 | $ -17.73M | -1773.1% | $ 1M |
12/31/2024 | $ -19.36M | -1935.6% | $ 1M |
9/30/2024 | $ -18.9M | 0% | $ 0 |
6/30/2024 | $ -19.96M | 0% | $ 0 |
3/31/2024 | $ -18.86M | 0% | $ 0 |
12/31/2023 | $ -20.03M | 0% | $ 0 |
9/30/2023 | $ -22.43M | 0% | $ 0 |
6/30/2023 | $ -22.85M | 0% | $ 0 |
3/31/2023 | $ -23.72M | 0% | $ 0 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for LISATA THERAPEUTICS INC is calculated as follows: CF - Operations [ $ -7.48M ] / Revenues [ $ 0 ]
(=) OCF % [ 0% ]
Minimum
Dec 31, 2024
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 78.12% |
average | 14.35% |
median | 12.67% |
std | 21.14% |